Literature DB >> 28454357

Expression, regulation and function of miR-495 in healthy and tumor tissues.

Hongli Chen1, Xiaman Wang1, Ju Bai1, Aili He1,2.   

Abstract

MicroRNA-495 (miR-495) is a small non-coding RNA encoded by a gene located on chromosome 14 (14q32.31). Its expression is regulated by the transcription factors EF12 and EF47, in addition to promoter methylation status and the fusion oncoprotein mixed-lineage leukemia-AF9. Previous studies suggest that miR-495 is involved in various developmental, immunological and inflammatory processes in healthy tissue, and in the proliferation, invasion, metastasis and drug resistance of cancer cells. The role miR-495 serves in tumors is controversial. miR-495 primarily functions as a tumor suppressor; however, in a number of cases it acts as an oncogene. miR-495 has potential applications as a diagnostic and prognostic marker, and as a therapeutic target for genetic and pharmacological manipulation in the treatment of various diseases.

Entities:  

Keywords:  14q32.31 cluster; expression regulation; function; miRNA-495

Year:  2017        PMID: 28454357      PMCID: PMC5403365          DOI: 10.3892/ol.2017.5727

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  44 in total

1.  microRNA-495 inhibits chondrogenic differentiation in human mesenchymal stem cells by targeting Sox9.

Authors:  Seulgi Lee; Dong Suk Yoon; Seungil Paik; Kyoung-Mi Lee; Yeonsue Jang; Jin Woo Lee
Journal:  Stem Cells Dev       Date:  2014-04-28       Impact factor: 3.272

2.  Emerging role of microRNAs to tackle drug resistance in pancreatic cancer.

Authors:  Albrecht Neesse; Thomas M Gress
Journal:  Gut       Date:  2015-06-03       Impact factor: 23.059

3.  Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures.

Authors:  Mansi A Parasramka; Shadan Ali; Sanjeev Banerjee; Tara Deryavoush; Fazlul H Sarkar; Smitiv Gupta
Journal:  Mol Nutr Food Res       Date:  2013-01-07       Impact factor: 5.914

4.  Mining cancer gene expression databases for latent information on intronic microRNAs.

Authors:  Simona Monterisi; Giovanni D'Ario; Elisa Dama; Nicole Rotmensz; Stefano Confalonieri; Chiara Tordonato; Flavia Troglio; Giovanni Bertalot; Patrick Maisonneuve; Giuseppe Viale; Francesco Nicassio; Manuela Vecchi; Pier Paolo Di Fiore; Fabrizio Bianchi
Journal:  Mol Oncol       Date:  2014-10-15       Impact factor: 6.603

Review 5.  Colorectal cancer epigenetics: complex simplicity.

Authors:  Manon van Engeland; Sarah Derks; Kim M Smits; Gerrit A Meijer; James G Herman
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

6.  Recent insights into the genetics of inflammatory bowel disease.

Authors:  Judy H Cho; Steven R Brant
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 7.  Logic and extent of miRNA-mediated control of autoimmune gene expression.

Authors:  Carola G Vinuesa; Robert J Rigby; Di Yu
Journal:  Int Rev Immunol       Date:  2009       Impact factor: 5.311

8.  miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A).

Authors:  Liqiang Song; Yan Li; Weina Li; Shouzhen Wu; Zhikui Li
Journal:  J Cell Biochem       Date:  2014-07       Impact factor: 4.429

9.  MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia.

Authors:  Xi Jiang; Hao Huang; Zejuan Li; Chunjiang He; Yuanyuan Li; Ping Chen; Sandeep Gurbuxani; Stephen Arnovitz; Gia-Ming Hong; Colles Price; Haomin Ren; Rejani B Kunjamma; Mary Beth Neilly; Justin Salat; Mark Wunderlich; Robert K Slany; Yanming Zhang; Richard A Larson; Michelle M Le Beau; James C Mulloy; Janet D Rowley; Jianjun Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-06       Impact factor: 11.205

10.  MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6.

Authors:  Shu-Mei Chen; Hua-Chien Chen; Shu-Jen Chen; Chiung-Yin Huang; Pin-Yuan Chen; Tai-Wei Erich Wu; Ly-Ying Feng; Hong-Chieh Tsai; Tai-Ngar Lui; Chuen Hsueh; Kuo-Chen Wei
Journal:  World J Surg Oncol       Date:  2013-04-17       Impact factor: 2.754

View more
  13 in total

1.  Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients.

Authors:  Dominika Wcisło-Dziadecka; Beniamin Grabarek; Celina Kruszniewska-Rajs; Andrzej Swinarew; Krzysztof Jasik; Beata Rozwadowska; Agata Krawczyk
Journal:  Postepy Dermatol Alergol       Date:  2020-11-07       Impact factor: 1.837

Review 2.  Cholino-ncRNAs modulate sex-specific- and age-related acetylcholine signals.

Authors:  Nimrod Madrer; Hermona Soreq
Journal:  FEBS Lett       Date:  2020-05-04       Impact factor: 4.124

3.  MicroRNA-495 serves as a diagnostic biomarker in patients with sepsis and regulates sepsis-induced inflammation and cardiac dysfunction.

Authors:  Hailei Guo; Liying Tang; Jianjun Xu; Cai Lin; Xiangwei Ling; Caijiao Lu; Zhengjun Liu
Journal:  Eur J Med Res       Date:  2019-11-26       Impact factor: 2.175

4.  Synthetic Artificial Long Non-coding RNA Shows Higher Efficiency in Specific Malignant Phenotype Inhibition Compared to the CRISPR/Cas Systems.

Authors:  Lin Yao; Quan Zhang; Aolin Li; Binglei Ma; Zhenan Zhang; Jun Liu; Lei Liang; Shiyu Zhu; Ying Gan; Qian Zhang
Journal:  Front Mol Biosci       Date:  2020-12-09

5.  LncRNA UCA1 mediates Cetuximab resistance in Colorectal Cancer via the MiR-495 and HGF/c-MET Pathways.

Authors:  Heng-Heng Yuan; Xin-Chen Zhang; Xiao-Li Wei; Wen-Jie Zhang; Xiao-Xue Du; Peng Huang; Hao Chen; Lu Bai; Hong-Feng Zhang; Yu Han
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

6.  MicroRNA miR-495 regulates the development of Hepatocellular Carcinoma by targeting C1q/tumor necrosis factor-related protein-3 (CTRP3).

Authors:  Ruiguang Zhang; Chunxia Guo; Ting Liu; Wenting Li; Xiliu Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Downregulation of MicroRNA-495 Alleviates IL-1β Responses among Chondrocytes by Preventing SOX9 Reduction.

Authors:  Soyeong Joung; Dong Suk Yoon; Sehee Cho; Eun Ae Ko; Kyoung Mi Lee; Kwang Hwan Park; Jin Woo Lee; Sung Hwan Kim
Journal:  Yonsei Med J       Date:  2021-07       Impact factor: 2.759

8.  Detection of Extracellular Vesicle RNA Using Molecular Beacons.

Authors:  Getulio Pereira de Oliveira; Eric Zigon; Gaenna Rogers; Danny Davodian; Shulin Lu; Tijana Jovanovic-Talisman; Jennifer Jones; John Tigges; Sanjay Tyagi; Ionita Calin Ghiran
Journal:  iScience       Date:  2019-12-19

9.  CircSERPINE2 weakens IL-1β-caused apoptosis and extracellular matrix degradation of chondrocytes by regulating miR-495/TGFBR2 axis.

Authors:  Qingpu Zhang; Xiaomiao Qiao; Wenwei Xia
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

10.  Statin suppresses sirtuin 6 through miR-495, increasing FoxO1-dependent hepatic gluconeogenesis.

Authors:  Min Yan Shi; In Hyuk Bang; Chang Yeob Han; Dae Ho Lee; Byung-Hyun Park; Eun Ju Bae
Journal:  Theranostics       Date:  2020-09-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.